Japan’s Fujifilm Electronic Materials is to invest about $140 million to enhance the development, production and quality evaluation functions for advanced semiconductor materials at two sites in Japan. This comes in response to growing demand for semiconductors in both volume and quality terms and follows the start-up of a CMP slurries plant at Kumamoto in January.

Fujifilm has entered into a definitive agreement to acquire KMG Corporation, the semiconductor high purity process chemicals (HPPC) business of Entegris for $700 million. This will bring it 12 new sites, including seven manufacturing sites in the US, Europe and Singapore, employing about 560.

The company said that it will now be able to offer a wider range of electronic chemicals, including KMG’s line of HPPCs for etching and cleaning silicon wafers. It will also add KMG’s Total Chemical Management (TCM) business, which includes logistical services in Southeast Asia and Europe.

The ongoing race to develop the first effective vaccines for the treatment of COVID-19 continues to generate manufacturing and development agreements between pharmaceutical giants, biotechs and CDMOs.

Most recently, Sterling Pharma Solutions agreed to carry out final purification of drug product for Moleculin Biotech’s WP1122 drug candidate from its site in Cary, North Carolina. Moleculin is about to submit an IND for this to the FDA and wanted a reliable source of supply in the US.